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Between December 2008 and September 2009, 11 
cases of invasive meningococcal disease (IMD) group 
B were reported in a 20 km diameter area in the 
Département Landes, France. Two of them presented 
with purpura fulminans and one of them died. The 
strain responsible for this community outbreak was of 
the clonal complex ST-269.The incidence rate for IMD 
group B was 3 per 100,000 inhabitants in Landes from 
week 40 in 2008 to week 40 in 2009; it was the high-
est in France during that period. The number of cases 
observed was significantly higher than expected, 
especially in young adults (standardised incidence 
ratio: 23.5, p<0.001). A nightclub located in the 20 km 
diameter area was a possible place of transmission 
and a prophylaxis recommended for the staff mem-
bers helped in decreasing the transmission. However, 
several cases notified later suggested that the bacte-
ria circulated during several months through healthy 
carriers in the community. This situation prompted 
increased surveillance of IMD in Landes and medical 
practitioners were asked to remain vigilant because of 
the possible emergence of new cases within the fol-
lowing months.
Introduction
Invasive meningococcal disease (IMD) is a severe infec-
tion that can create concerns in the population. The 
disease is notifiable in France [1] and following each 
notification, control measures are implemented by the 
concerned health district office in order to prevent sec-
ondary cases. Outbreaks are rare and when they occur, 
the French Institute for Public Health (InVS) may inter-
vene to carry out an epidemiological investigation.
In December 2008, one case of IMD group B was 
reported to a health district office in the Département 
Landes (population 375,000), Aquitaine region. One 
month later, four more cases of IMD group B were 
reported to the same health district office within 
one week. This number was unusually high; the total 
number of cases notified to this department had 
been seven in 2007 and four in 2006. Furthermore, 
all five cases were living within a limited area of the 
Département. 
An epidemiological investigation was therefore initi-
ated in January 2009 by the local InVS team in collabo-
ration with the health district department of Landes. 
The aims were to describe characteristics of the cases 
and their potential epidemiological links, to identify 
the source of infection and to suggest control and pre-
ventive measures.
Methods
Cases were reported to the health district department 
by hospital practitioners through the French surveil-
lance system of IMD. Since 2006, the case definition of 
IMD in France has been the following [1]:
•	  Either a patient laboratory-confirmed by at least 
one of the following methods: 
	 •	detection	of Neisseria meningitidis by culture and/
or detection of N. meningitidis nucleic acid by PCR 
from any sterile site; 
	 •	detection	of	Gram-negative	diplococci	in	cerebros-
pinal fluid (CSF); 
	 •	SF	 findings	 compatible	 with	 bacterial	 meningitis	
together with detection of N. meningitidis antigens 
in blood, urine or CSF; 
•	 Or a patient with clinical presentation suggestive of 
IMD (CSF findings compatible with bacterial menin-
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gitis together with a petechial rash and /or purpura 
fulminans (haemorrhagic septic shock). 
All cases of IMD group B notified from December 2008 
onwards who were living, working or going to school 
in the Département Landes were interviewed by the 
health district department or by epidemiologists of 
the local InVS team. Information on sociodemographic 
characteristics, medical history were collected, as well 
as on activities within the 10 days before symptoms 
onset (work  or school place, travel, meetings, celebra-
tions and any other occasion involving close contacts). 
Specimens from each case were sent to the national 
reference centre for meningococci (CNR) for complete 
typing that consists of phenotyping (serogroup:sero
type:serosubtype) and genotyping using multilocus 
sequence typing (MLST) [2] as well as typing of porA. 
The study area was defined as the smallest area cover-
ing all cases occurred. Incidence of IMD by age group 
was estimated in this area and in the Département 
Landes and compared with the incidence in the rest of 
France. The number of expected cases in Landes was 
estimated by age group using incidence rates of IMD 
group B in the rest of France (indirect standardisation). 
Standardised incidence ratios (SIR, ratio of observed to 
expected cases) was calculated for each group. 
Results 
Outbreak description
A total of 11 cases of IMD group B were notified in 
Landes between December 2008 and September 2009 
(Figure 1). The cases were localised in an area of 20 km 
Figure 2
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Cases of invasive meningococcal disease group B by 
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Landes, France (N=11)
Source : French Institute for Public Health, 2009.
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diameter (population 125,000) near the city of Dax, in 
the south west of the Département Landes.
The age range of the cases was between seven months 
and 47 years (median age: 18 years), six cases were 
male. Two cases presented with purpura fulminans and 
one of them (a four-year-old child) died the day after 
hospitalisation. The nine other cases fully recovered a 
few days after their admission to hospital. 
Eight of the 11 cases lived in the Dax area perma-
nently, two during week-ends and holidays only, and 
one only during the week. No case of IMD was reported 
in the rest of the Département or in the neighbour-
ing Département (Pyrénées-Atlantiques) between 
December 2008 and September 2009. 
Relations between cases 
Epidemiological investigations could not identify a 
common link among the first eight cases. However, 
three of them went to the same nightclub on different 
nights within 10 days before symptoms onset and three 
others had relatives or friends working at the nightclub 
(Figure 2). The ninth and tenth case (onset in May 2009) 
were friend or family of respectively one and two previ-
ous cases. No link with other cases was found for the 
last case that occurred in September 2009. No other 
common place or more confined community (school, 
social group, etc.) was identified.
Incidence rates
The incidence rate for group B IMD was 3 per 100,000 
inhabitants in the Département Landes and 8.9 in 
the affected area of Dax, whereas the incidence in 
the same time period at national level was 0.6 per 
100,000 (Table). The incidence in Landes was the 
highest observed in any French Département in the 
period under investigation. For all age groups, the 
observed number of cases was 4.5 times higher than 
the expected number of cases (p<0.001).
The age distribution of the cases in Landes differed 
from that observed for the whole of France in that four 
(36%) of the Landes cases were between 20 and 24 
years of age, whereas at the national level this age 
group only represented 10% in 2008. The incidence 
rate was therefore particularly high in this age group 
(25.1/100,000) and the number of cases observed was 
23.5 times higher than expected (p<0.001). A similar 
but less pronounced trend was observed in the group 
of 15-19-year-olds with the number of observed cases 
nearly seven times higher than the number of expected 
cases (p=0.08) (Table).
Laboratory investigation
All 11 cases were laboratory-confirmed as infected with 
N. meningitidis serogroup B and further analyses were 
performed by the CNR on 10 specimens (testing was 
technically not possible for one specimen). The strains 
were not typable and not serosubtypable (B:NT:NST). 
PorA sequencing revealed identical variable regions 
(VR) among most of the tested isolates (VR1=19-1; 
VR2=15-11) (9 of 10 strains tested) and MLST analy-
sis clustered these isolates in the clonal complex 
(CC) ST-269. All the tested isolates were susceptible 
to the antibiotics that are currently used in treatment 
and	 prophylaxis	 (rifampicin,	 cefotaxime,	 penicillin	 G,	
ciprofloxacin).
Control measures
In order to prevent further spread of the disease and 
according to the national recommendations and policy 
[1], individual control measures were implemented for 
each case by the local health department, including 
post-exposure chemoprophylaxis for all close contacts 
of cases.
Furthermore, prophylaxis with rifampicin was recom-
mended for the nightclub staff (10 people) at the end 
of February 2009, after the occurrence of several cases 
who had a direct or indirect link with this venue. All 
general practitioners and acute care hospital practi-
tioners were sent an email describing the outbreak. 
They were alerted to be vigilant and notification was 
encouraged. Information on early symptoms of IMD 
Table
Cases of invasive meningococcal disease group B and incidence rates by age group for the Département Landes (52 weeks: 
from week 40 in 2008 to week 40 in 2009) and the rest of France (year 2008)
  Incidence rate in the Département Landes Incidence rate in the rest of France
a Estimation of the risk excess  
in the Département Landes
Age groups 
(years)
Number of 
cases (%)
Incidence per 
100,000 Number of cases (%)
Incidence per 
100,000
Number of 
cases SIR
b pc Confidence  interval
<5 3 27 15.5 189 46 4.8 0.94 3.2 0.14 0.6 - 9.2
 5-14 1 9 2.4 43 10 0.5 0.23 4.3 0.41 0.1 - 24.2
15-19 2 18 10.0 63 15 1.5 0.30 6.7 0.08 0.7 - 24.1
20-24 4 36 25.1 42 10 1.0 0.17 23.5 <0.001 6.3 - 60.2
≥25 1 9 0.4 77 19 0.2 0.48 2.1 0.75 0.0 - 11.6
Total 11 100 3.0 414 100 0.6 2.41 4.6 <0.001 2.3 - 8.2
a excluding Landes.
b Standardised incidence ratio : ratio of observed to expected cases.
c p-value number of observed cases ≠ number of expected cases.
Source : French Institute for Public Health, 2009.
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was communicated to the general population through 
the local press. 
Discussion and conclusion
Between December 2008 and September 2009, an 
outbreak of group B IMD occurred in the French 
Département of Landes. It was caused by one clone of 
N. meningitidis belonging to the CC ST-269. The cases 
were concentrated in a limited geographical area, with 
an unusually high incidence rate compared with the 
preceding years: since the year 2000, the mean annual 
incidence rate of group B IMD has been 1.4 per 100,000 
inhabitants in Landes (data from the French surveil-
lance system of IMD [3])
The investigation suggested that the nightclub was one 
place of transmission of the disease and, as no cases 
were notified for the two months following the imple-
mentation of the recommendation (Case 8 occurred at 
the end of April), that the prophylaxis recommended for 
the staff members of the nightclub in February helped 
to stop the transmission. 
The appearance of new cases that were not related to 
the nightclub but to previous cases, suggested that 
bacteria had circulated during several months through 
healthy carriers. Indeed, it was shown that at any time, 
approximately 10% of the general population were car-
rying N. meningitidis in the nasopharynx and that the 
carriage rate was 30% in teenagers and young adults 
[4]. Moreover, the time intervals between the occur-
rence of cases who knew each other were not consist-
ent with a direct transmission. 
In this outbreak, the age group of 15-24-year-olds 
seems to have been particularly affected. Teenagers 
and young adults have been shown previously to be at 
higher risk during IMD outbreaks [5-7]. This could be 
due to lifestyle since an active social life can increase 
the risk of infection when bacteria circulate in the pop-
ulation. Moreover, as nightclubs are mainly frequented 
by teenagers and young adults, high incidence among 
this group may also be a consequence of the nightclub 
as a possible place of transmission.
However, a shift in the age distribution of meningococ-
cal disease towards higher age groups (≥ 20 years-old) 
can be observed during outbreaks and epidemics fol-
lowing the introduction of new clone [8].
Since 2007 there has been an increase of CC ST-269 iso-
lates in France: 10% of the strains responsible for IMD 
analysed by the CNR in 2009 belonged to this CC (5% 
in the last ten years). These isolates may differ in viru-
lence, as has been observed for the common CCs ST-32 
and ST 41/44 [9], and seem to be highly transmissible. 
Since no universal vaccine against serogroup B exists, 
the relevance of implementing a mass chemoprophy-
laxis was widely discussed by local authorities and 
national experts on IMD infections. This strategy had 
been implemented twice before in France to control 
IMD group B outbreaks confined to small areas [10,11]. 
However, it was finally not recommended in the Landes 
department because of the dynamics of the outbreak: 
indeed, cases were spread over time and space and 
were part of an open population. Such a recommenda-
tion would have had a limited effect because of a high 
risk that individuals not targeted by the prophylaxis 
would rapidly reintroduce the bacteria in the treated 
population [12]. In a larger epidemic of group B IMD 
that recently occurred in another French Département, 
a massive preventive intervention could be launched 
because an unlicensed outer membrane vesicle vac-
cine was available against the strain responsible for 
the outbreak [5]. 
General	 and	 acute	 care	 hospital	 practitioners	 were	
asked to remain vigilant in case new cases should 
emerge in the following months. No new case was 
reported until the end of 2009, but the increased sur-
veillance implemented during this outbreak showed 
that the bacteria are still present in the Département 
Landes in 2010. Indeed, two cases of group B meningo-
coccal disease infected with N. meningitidis CC ST-269 
were reported in January and August 2010; one died a 
few days after hospitalisation. Both were living in the 
Dax area.
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